These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 22241356)
1. [Impact on opioid precipitation of opioid-starting titration path]. Fukumoto K; Morita T; Kawaguchi T; Fukazawa A; Hori Y; Takashina Y; Tanaka T; Onishi K; Sakaguchi T; Inaba K; Konno H Gan To Kagaku Ryoho; 2012 Jan; 39(1):81-4. PubMed ID: 22241356 [TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
3. Prescribing of pain medication in palliative care. A survey in general practice. Borgsteede SD; Deliens L; Zuurmond WW; Schellevis FG; Willems DL; Van der Wal G; van Eijk JT Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):16-23. PubMed ID: 18985638 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes during opioid titration following initiation with or conversion to Remoxy®, an extended-release formulation of oxycodone. Roland CL; Setnik B; Cleveland JM; Brown DA Postgrad Med; 2011 Jul; 123(4):148-59. PubMed ID: 21680999 [TBL] [Abstract][Full Text] [Related]
5. The use of high doses of oxycodone in an acute palliative care unit. Mercadante S; Ferrera P; David F; Casuccio A Am J Hosp Palliat Care; 2011 Jun; 28(4):242-4. PubMed ID: 20826490 [TBL] [Abstract][Full Text] [Related]
6. Oxycodone and a useful book. Enck RE Am J Hosp Palliat Care; 2011 Jun; 28(4):217-8. PubMed ID: 21622488 [No Abstract] [Full Text] [Related]
7. Opioid switch in palliative care, opioid choice by clinical need and opioid availability. Müller-Busch HC; Lindena G; Tietze K; Woskanjan S Eur J Pain; 2005 Oct; 9(5):571-9. PubMed ID: 16139186 [TBL] [Abstract][Full Text] [Related]
8. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model. Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815 [TBL] [Abstract][Full Text] [Related]
9. Clinical pathways can improve the quality of pain management in home palliative care in remote locations: retrospective study on Kozu Island, Japan. Tateno Y; Ishikawa S Rural Remote Health; 2012; 12():1992. PubMed ID: 23116429 [TBL] [Abstract][Full Text] [Related]
10. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438 [TBL] [Abstract][Full Text] [Related]
11. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study. Singla N; Pong A; Newman K; Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets. Koizumi W; Toma H; Watanabe K; Katayama K; Kawahara M; Matsui K; Takiuchi H; Yoshino K; Araki N; Kodama K; Kimura H; Kono I; Hasegawa H; Hatanaka K; Hiraga K; Takeda F Jpn J Clin Oncol; 2004 Oct; 34(10):608-14. PubMed ID: 15591459 [TBL] [Abstract][Full Text] [Related]
13. [Use of opioids against severe cancer pain]. Borchgrevink PC; Klepstad P; Kongsgaard UE; Kaasa S Tidsskr Nor Laegeforen; 2004 Feb; 124(3):337-8. PubMed ID: 14963506 [No Abstract] [Full Text] [Related]
14. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone. Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453 [TBL] [Abstract][Full Text] [Related]
15. High dose controlled-release oxycodone in hospice care. Bercovitch M; Adunsky A J Pain Palliat Care Pharmacother; 2006; 20(4):33-9. PubMed ID: 17182504 [TBL] [Abstract][Full Text] [Related]
16. Prescription and administration of opioids to hospital in-patients, and barriers to effective use. Murnion BP; Gnjidic D; Hilmer SN Pain Med; 2010 Jan; 11(1):58-66. PubMed ID: 19930113 [TBL] [Abstract][Full Text] [Related]
17. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Portenoy RK; Farrar JT; Backonja MM; Cleeland CS; Yang K; Friedman M; Colucci SV; Richards P Clin J Pain; 2007 May; 23(4):287-99. PubMed ID: 17449988 [TBL] [Abstract][Full Text] [Related]
18. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM; Messina J; Xie F; Hale M Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282 [TBL] [Abstract][Full Text] [Related]
19. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Ytterberg SR; Mahowald ML; Woods SR Arthritis Rheum; 1998 Sep; 41(9):1603-12. PubMed ID: 9751092 [TBL] [Abstract][Full Text] [Related]
20. [Clinical efficacy of oxycodone against cancer-related pain with a wide variety of pathophysiologies]. Sumitani M; Yamada Y Gan To Kagaku Ryoho; 2011 Jun; 38(6):977-82. PubMed ID: 21677490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]